The detailed controlling mechanism of the malignant properties of cancer cells by this glycosylation remains to be elucidated, but the β4GalNAcT3 gene, the β4GalNAcT4 gene, and their antisense oligonucleotides have to be evaluated as new cancer therapy agents for several tumors. Here, B4GALNT3 is linked to cancer.